CSO Rob Roscow: Transforming Research From Mydecine’s 3 Pillars Into Repeatable Medicine Mar 23, 2021
Creso Pharma is an “Open Minded Company” Providing Investors Optionality, says Bruce Linton Mar 22, 2021
Numinus Science Officer Sharan Sidhu: We Won’t Patent IP That Makes Psychedelics Inaccessible Mar 19, 2021
Matt Hawkins From Entourage Effect Capital On SAFE Banking: I Think It Will Pass The Senate Very Easily Mar 18, 2021
Similar to Cannabis Capital Market Structure: Horizons ETFs CEO on Psychedelics Industry Mar 12, 2021
